Human cardiomyocyte progenitor cells: a short history of nearly everything

Patrick van Vliet, Marie-Jose Goumans*, Pieter A. Doevendans, Joost P. G. Sluijter

*Corresponding author for this work

Research output: Contribution to journalLiterature reviewpeer-review

Abstract

The high occurrence of cardiac disease in the Western world has driven clinicians and cardiovascular biologists to look for alternative strategies to treat patients. A challenging approach is the use of stem cells to repair the heart, in itself an inspiring thought. In the past 10 years, stem cells from different sources have been under intense investigation and, as a result, a multitude of studies have been published on the identification, isolation, and characterization, of cardiovascular progenitor cells and repair in different animal models. However, relatively few cardiovascular progenitor populations have been identified in human hearts, including, but not limited to, cardiosphere-derived cells , cKit+ human cardiac stem cells , Isl1+ cardiovascular progenitors , and, in our lab, cardiomyocyte progenitor cells (CMPCs) . Here, we aim to provide a comprehensive summary of the past findings and present challenges for future therapeutic potential of CMPCs.

Original languageEnglish
Pages (from-to)1669-1673
Number of pages5
JournalJournal of Cellular and Molecular Medicine
Volume16
Issue number8
DOIs
Publication statusPublished - Aug 2012

Keywords

  • cardiac stem cells
  • regeneration
  • microRNA
  • miRNA
  • cell therapy
  • apoptosis
  • necrosis
  • MESENCHYMAL STEM-CELLS
  • OXYGEN-TENSION
  • IN-VITRO
  • PROLIFERATION
  • DIFFERENTIATION
  • CULTIVATION
  • HEART
  • RIP1

Fingerprint

Dive into the research topics of 'Human cardiomyocyte progenitor cells: a short history of nearly everything'. Together they form a unique fingerprint.

Cite this